Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

TR SCAN : revenue, balance sheet and financial ratios

TR SCAN is a French company founded 10 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in BASTIA (20200), this company of category PME shows in 2021 a net income positive of 174 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - TR SCAN (SIREN 812278711)
Indicator 2021
Revenue N/C
Net income 174 199 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2021, TR SCAN generates positive net income of 174 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

174 199 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 7%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 74%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

6.627%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

74.132%

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

19.8%

Solvency indicators evolution
TR SCAN

Sector positioning

Debt ratio
6.63 2021
2021
Q1: 4.54
Med: 28.23
Q3: 74.56
Good

In 2021, the debt ratio of TR SCAN (6.63) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
74.13% 2021
2021
Q1: 23.22%
Med: 44.96%
Q3: 63.76%
Excellent

In 2021, the financial autonomy of TR SCAN (74.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 259.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

259.842

Liquidity indicators evolution
TR SCAN

Sector positioning

Liquidity ratio
259.84 2021
2021
Q1: 163.32
Med: 243.69
Q3: 375.82
Good

In 2021, the liquidity ratio of TR SCAN (259.84) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of TR SCAN in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Valuation estimate

Based on 57 transactions of similar company sales (all years), the value of TR SCAN is estimated at 530 554 € (range 123 294€ - 1 046 229€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2021
57 tx
123k€ 530k€ 1046k€
530 554 € Range: 123 294€ - 1 046 229€
NAF 5 all-time

Valuation method used

Net Income Multiple
174 199 € × 3.0x = 530 554 €
Range: 123 294€ - 1 046 230€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare TR SCAN with other companies in the same sector:

Frequently asked questions about TR SCAN

What is the revenue of TR SCAN ?

The revenue of TR SCAN is not publicly disclosed (confidential accounts filed with INPI).

Is TR SCAN profitable?

Yes, TR SCAN generated a net profit of 174 k€ in 2021.

Where is the headquarters of TR SCAN ?

The headquarters of TR SCAN is located in BASTIA (20200).

Where to find the tax return of TR SCAN ?

The tax return of TR SCAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does TR SCAN operate?

TR SCAN operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.